SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.74+2.7%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Moerman who wrote (17451)3/15/1998 2:42:00 AM
From: John O'Neill  Read Replies (2) of 32384
 
Paul..I picked MLNM for diversification.

They are into genetic, genomics and bioinfomatics approaches to the development of novel drug therapies. This seems to augment LGND's work in other areas. MLNM is well financed and appears to me to be promising for long term. Check out the Forbes 1/28/98 issue with chips and biotech on the cover at Forbes website. MLNM has a lot of deals in the works.

I'd like to get Henry's opinion. Maybe we should all chip in and put him on $$ retainer for biotech research. I like LGND a lot, but still want to diversify biotech holdings.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext